論文（英文）

• Kuwabara M, Oba K, Takano N, Nagamine N, Maruyama Y, Ito N, Watanabe I, Ikeda C, Sakamoto J. An exploratory questionnaire survey about overwork on mental health of Japanese elementary and junior high school teachers. J Ment Health Train Educ Pract 2021. https://doi.org/10.1108/JMHTEP-01-2020-0002
• Takahashi T, Yamazaki K, Oki E, Shiozawa M, Mitsugi K, Makiyama A, Nakamura M, Ojima H, Kagawa Y, Matsuhashi N, Okuda H, Asayama M, Yuasa Y, Shimada Y, Manaka D, Watanabe J, Oba K, Yoshino T, Yoshida K, Maehara Y. Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7. ESMO Open. 2021;6: 100093.
• Shimada H, Fukagawa T, Haga Y, Okazumi S, Oba K. Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature. Ann Gastroenterol Surg. 2021 Jul; 5(4): 404–418.
• Ota K, Oba K, Fukui K, Ito Y, Hamada E, Mori N, Oka M, Ota K, Shibata Y, Takasu A. Sites of blood collection and topical antiseptics associated with contaminated cultures: prospective observational study. Sci Rep. 2021 Mar 18;11(1):6211.
• Kuzumi A, Yoshizaki A, Ebata S, Fukasawa T, Yoshizaki-Ogawa A, Asano Y, Oba K, Sato S. Serum TARC Levels in Patients with Systemic Sclerosis: Clinical Association with Interstitial Lung Disease. J Clin Med. 2021 Feb 9;10(4):660.
• Ishibashi K, Aoyama T, Kotaka M, Satake H, Tsuji Y, Kataoka M, Nakamura M, Nagata N, Sakamoto J, Oba K, Mishima H. Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study). Cancer Chemother Pharmacol. 2021 May;87(5):665-672.
• Kotani H, Yoshizaki A, Matsuda KM, Norimatsu Y, Kuzumi A, Fukayama M, Fukasawa T, Ebata S, Yoshizaki-Ogawa A, Asano Y, Oba K, Sato S. Serum Calponin 3 Levels in Patients with Systemic Sclerosis: Possible Association with Skin Sclerosis and Arthralgia. J Clin Med. 2021 Jan 14;10(2):280.
• Norimatsu Y, Yoshizaki Y, Fukasawa T, Ebata S, Oba K, Sato S. COVID-19 pandemic highlighted the importance of telemedicine in the collagen disease of systemic sclerosis (Letters to the Editors). Clin Exp Rheumatol 2020.
• Misawa F, Okumura Y, Takeuchi Y, Fujii Y, Takeuchi H. Neuroleptic malignant syndrome associated with long-acting injectable second-generation antipsychotics versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database ㏌ Japan. Schizophr Res. 2021; 231: 42-46.
• Hirose N, Morita K, Jo T, Hagiwara Y, Matsui H, Fushimi K, Yasunaga H. Differences in disease severity and in-hospital mortality in patients hospitalised for pneumonia with and without intellectual disabilities: A matched-pair retrospective cohort study using nationwide in-patient database. J Intellect Dev Disabil. Online ahead of print.
• Takeuchi Y, Kumamaru H, Hagiwara Y, Matsui H, Yasunaga H, Miyata H, Matsuyama Y. Sodium-glucose cotransporter-2 inhibitors and the risk of urinary tract infection among diabetic patients in Japan: Target trial emulation using a nationwide administrative claims database. Diabetes Obes Metab. 2021; 23(6): 1379-1388.
• Taniguchi Y, Kitamura A, Abe T, Kojima G, Shinozaki T, Seino S, Yokoyama Y, Nofuji Y, Ikeuchi T, Matsuyama Y, Fujiwara Y, Shinkai S. Associations of aging trajectories for an index of frailty score with mortality and medical and long-term care costs among older Japanese undergoing health checkups. Geriatr Gerontol Int. 2020; 20(11): 1072-1078.
• Nishi D, Imamura K, Watanabe K, Obikane E, Sasaki N, Yasuma N, Sekiya Y, Matsuyama Y, Kawakami N. Internet-based cognitive-behavioural therapy for prevention of depression during pregnancy and in the post partum (iPDP): a protocol for a large-scale randomised controlled trial. BMJ Open. 2020; 10(5): e036482.
• Kawahara T, Shinozaki T, Matsuyama Y. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin. BMC Med Res Methodol. 2020; 20(1): 204.
• Yamashita S, Shinozaki T, Murata H, Matsuyama Y, Babazono T. Panel of novel urine biomarkers for incident microalbuminuria in people with type 2 diabetes mellitus. Diabetic Medicine 2020; 37: 1910-8.
• Watanabe Y, Matsuyama Y, Izumi N, Kubo S, Kokudo N, Sakamoto M, Shiina S, Takayama T, Nakashima O, Kudo M. Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: A nationwide survey of the Liver Cancer Study Group of Japan. Surgery. 2020; 167(5): 793-802.
• Fukami Y, Kaneoka Y, Maeda A, Kumada T, Tanaka J, Akita T, Kubo S, Izumi N, Kadoya M, Sakamoto M, Nakashima O, Matsuyama Y, Kokudo T, Hasegawa K, Yamashita T, Kashiwabara K, Takayama T, Kokudo N, Kudo M; Liver Cancer Study Group of Japan. Liver resection for multiple hepatocellular carcinomas: A Japanese nationwide survey. Annals of Surgery 2020; 272(1): 145-154.
• Yoshida Y, Kashiwabara K, Hirakawa Y, Tanaka T, Noso S, Ikegami H, Ohsugi M, Ueki K, Mita T, Watada H, Koya D, Mise K, Wada J, Shimizu M, Wada T, Ito Y, Narita I, Kashihara N, Nangaku M, Matsuyama Y. Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan. BMJ Open Diabetes Res Care. 2020; 8(1): e000902.
• Usui T, Yoshida Y, Nishi H, Yanagimoto S, Matsuyama Y, Nangaku M. Diagnostic accuracy of urine dipstick for proteinuria category in Japanese workers. Clin Exp Nephrol. 2020; 24(2): 151-156.
• Kudo M, Izumi N, Kubo S, Kokudo N, Sakamoto M, Shiina S, Tateishi R, Nakashima O, Murakami T, Matsuyama Y, Takahashi A, Miyata H, Takayama T. Report of the 20th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res. 2020; 50(1): 15-46.

TOP